BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 36971260)

  • 1. Low-grade inflammation during the glucocorticoid withdrawal phase in patients with Cushing's syndrome.
    Vogel F; Braun L; Zopp S; Nowak E; Schreiner J; Benz I; Rubinstein G; Künzel H; Ritzel K; Kroiss M; Honegger J; Beuschlein F; Schilbach K; Teupser D; Bidlingmaier M; Reincke M
    Eur J Endocrinol; 2023 Apr; 188(4):375-384. PubMed ID: 36971260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Persisting Muscle Dysfunction in Cushing's Syndrome Despite Biochemical Remission.
    Vogel F; Braun LT; Rubinstein G; Zopp S; Künzel H; Strasding F; Albani A; Riester A; Schmidmaier R; Bidlingmaier M; Quinkler M; Deutschbein T; Beuschlein F; Reincke M
    J Clin Endocrinol Metab; 2020 Dec; 105(12):e4490-8. PubMed ID: 32882010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Persistence of myopathy in Cushing's syndrome: evaluation of the German Cushing's Registry.
    Berr CM; Stieg MR; Deutschbein T; Quinkler M; Schmidmaier R; Osswald A; Reisch N; Ritzel K; Dimopoulou C; Fazel J; Hahner S; Stalla GK; Beuschlein F; Reincke M
    Eur J Endocrinol; 2017 Jun; 176(6):737-746. PubMed ID: 28325824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cushing's syndrome: update on signs, symptoms and biochemical screening.
    Nieman LK
    Eur J Endocrinol; 2015 Oct; 173(4):M33-8. PubMed ID: 26156970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of cortisol and ACTH responses to the desmopressin test in patients with Cushing's syndrome and simple obesity.
    Tsagarakis S; Vasiliou V; Kokkoris P; Stavropoulos G; Thalassinos N
    Clin Endocrinol (Oxf); 1999 Oct; 51(4):473-7. PubMed ID: 10583315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening for Cushing's syndrome in obese patients.
    Tiryakioglu O; Ugurlu S; Yalin S; Yirmibescik S; Caglar E; Yetkin DO; Kadioglu P
    Clinics (Sao Paulo); 2010; 65(1):9-13. PubMed ID: 20126340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. No requirement of perioperative glucocorticoid replacement in patients with endogenous Cushing's syndrome - a pilot study.
    Trummer C; Pandis M; Theiler-Schwetz V; Schmitt L; Obermayer-Pietsch B; Gellner V; Simon A; Pilz S
    Endocrine; 2024 Apr; ():. PubMed ID: 38647982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transsphenoidal pituitary surgery in Cushing's disease: can we predict outcome?
    Chee GH; Mathias DB; James RA; Kendall-Taylor P
    Clin Endocrinol (Oxf); 2001 May; 54(5):617-26. PubMed ID: 11380492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucocorticoid receptor polymorphism BclI with increased glucocorticoid sensitivity has a positive influence on quality of life in endogenous Cushing's syndrome in remission.
    Feldkamp L; Müller L; Deutschbein T; Detomas M; Hahner S; Strasburger CJ; Künzel H; Oßwald A; Braun L; Rubinstein G; Reincke M; Quinkler M; Kienitz T
    Eur J Endocrinol; 2023 Apr; 188(4):366-374. PubMed ID: 36995896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patients with low IGF-I after curative surgery for Cushing's syndrome have an adverse long-term outcome of hypercortisolism-induced myopathy.
    Vogel F; Braun L; Rubinstein G; Zopp S; Benedix S; Schneider H; Ritzel K; Schilbach K; Schmidmaier R; Beuschlein F; Bidlingmaier M; Reincke M
    Eur J Endocrinol; 2021 May; 184(6):813-821. PubMed ID: 33830940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cushing's syndrome in the elderly: data from the European Registry on Cushing's syndrome.
    Amodru V; Ferriere A; Tabarin A; Castinetti F; Tsagarakis S; Toth M; Feelders RA; Webb SM; Reincke M; Netea-Maier R; Kastelan D; Elenkova A; Maiter D; Ragnarsson O; Santos A; Valassi E;
    Eur J Endocrinol; 2023 Apr; 188(4):395-406. PubMed ID: 36749009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Undetectable postoperative cortisol does not always predict long-term remission in Cushing's disease: a single centre audit.
    Yap LB; Turner HE; Adams CB; Wass JA
    Clin Endocrinol (Oxf); 2002 Jan; 56(1):25-31. PubMed ID: 11849243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucocorticoid withdrawal syndrome following surgical remission of endogenous hypercortisolism: a longitudinal observational study.
    Zhang CD; Li D; Singh S; Suresh M; Thangamuthu K; Nathani R; Achenbach SJ; Atkinson EJ; Van Gompel JJ; Young WF; Bancos I
    Eur J Endocrinol; 2023 Jul; 188(7):592-602. PubMed ID: 37395115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dyslipidemia and chronic inflammation markers are correlated with telomere length shortening in Cushing's syndrome.
    Aulinas A; Ramírez MJ; Barahona MJ; Valassi E; Resmini E; Mato E; Santos A; Crespo I; Bell O; Surrallés J; Webb SM
    PLoS One; 2015; 10(3):e0120185. PubMed ID: 25799396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The low-dose dexamethasone suppression test in patients with adrenal incidentalomas: comparisons with clinically euadrenal subjects and patients with Cushing's syndrome.
    Tsagarakis S; Kokkoris P; Roboti C; Malagari C; Kaskarelis J; Vlassopoulou V; Alevizaki C; Thalassinos N
    Clin Endocrinol (Oxf); 1998 May; 48(5):627-33. PubMed ID: 9666875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deleterious effects of glucocorticoid replacement on bone in women after long-term remission of Cushing's syndrome.
    Barahona MJ; Sucunza N; Resmini E; Fernández-Real JM; Ricart W; Moreno-Navarrete JM; Puig T; Wägner AM; Rodriguez-Espinosa J; Farrerons J; Webb SM
    J Bone Miner Res; 2009 Nov; 24(11):1841-6. PubMed ID: 19453254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations in hypothalamic-pituitary-adrenal function immediately after resection of adrenal adenomas in patients with Cushing's syndrome and others with incidentalomas and subclinical hypercortisolism.
    Khawandanah D; ElAsmar N; Arafah BM
    Endocrine; 2019 Jan; 63(1):140-148. PubMed ID: 30259310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term remission rates after pituitary surgery for Cushing's disease: the need for long-term surveillance.
    Atkinson AB; Kennedy A; Wiggam MI; McCance DR; Sheridan B
    Clin Endocrinol (Oxf); 2005 Nov; 63(5):549-59. PubMed ID: 16268808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Body composition and bone mineral density in women with Cushing's syndrome in remission and the association with common genetic variants influencing glucocorticoid sensitivity.
    Ragnarsson O; Glad CA; Bergthorsdottir R; Almqvist EG; Ekerstad E; Widell H; Wängberg B; Johannsson G
    Eur J Endocrinol; 2015 Jan; 172(1):1-10. PubMed ID: 25422351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term cognitive effects of glucocorticoid excess in Cushing's syndrome.
    Forget H; Lacroix A; Bourdeau I; Cohen H
    Psychoneuroendocrinology; 2016 Mar; 65():26-33. PubMed ID: 26708069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.